Experimental Methods
Compound 2:
iii. To an oven-dried, round-bottom flask under N 2 was added anhydrous CH 2 Cl 2 (30 mL), vinyl iodide (5.31 g, 24.5 mmol, 1.0 equiv.), and imidazole (2.88 g, 42.3 mmol, 1.8 equiv.). The solution was stirred for 5 minutes at room temperature, then chilled to 0 ºC. t-Bu(Cl)Ph 2 Si (6.01 mL, 24.5 mmol, 1.0 equiv) was added dropwise via syringe and a white precipitate formed immediately. The reaction mixture was warmed to room temperature, then stirred for 1 hour.
The solution was diluted with CH 2 Cl 2 and washed with NH 4 Cl (2 x 25 mL), followed by brine (1 x 25 mL). The organic phase was dried over Na 2 SO 4 , concentrated under vacuum, and purified via flash column chromatography (Rf = 0.8 in 8:2 hexanes/EtOAc) to afford a mixture (trans:cis = 1.57:1) of t-BDPS protected vinyl iodide (8.34 g, 17.95 mmol, 73% yield) as a colorless oil. iv. To an oven-dried, round-bottom flask under N 2 was added CuI (108 mg, 0.56 mmol, 0.1 equiv.), acetamide (662 mg, 11.2 mmol, 2.0 equiv.), and Cs 2 CO 3 (2.737 g, 8.4 mmol, 1.5 equiv.). The solids were suspended in anhydrous THF (6 mL), and N,Ndimethylethylenediamine (122 µL, 1.12 mmol, 0.2 equiv.) was added dropwise. Separately, the tBDPS-protected vinyl iodide was dissolved in anhydrous THF (3 mL) and added dropwise to the acetamide solution via syringe. The reaction vessel was flushed with N 2 , sealed, and heated to 55 ºC overnight. The reaction mixture was cooled to room temperature, diluted with EtOAc (80 mL), and filtered over a pad of silica gel. After thorough washing, the combined organic solvent was concentrated under vacuum and the mixture (trans:cis = 4.6:1) was purified by flash column chromatography (cis Rf = 0.45, trans Rf = 0.40 in 1:1 hexanes/EtOAc). 
Compound 3:
v. To an oven-dried, round-bottom flask under N 2 was added the trans tBDPS-protected enamide (2.26 g, 5.68 mmol, 1.0 equiv.) and THF (12 mL). TBAF (8.52 mL, 1.0 M in THF, 1.5 equiv.) was added dropwise via syringe under N 2 , and the reaction was stirred at room temperature overnight. The solution was then filtered over a pad of silica gel that was prewashed with 94:5:1 CH 2 Cl 2 /MeOH/Et 3 N. After washing thoroughly, the combined organic solvent was concentrated under vacuum and purified by flash column chromatography (Rf = 0.25 in 94 
Compound 4:
viii. Zinc powder (8.11 mg, 0.12 mmol, 1.3 equiv.) was added to a solution of compound 3 (17.0 mg, 0.09 mmol, 1.0 equiv.) and ammonium chloride (11.6 mg, 0.22 mmol, 2.4 equiv.) in ethyl alcohol (248 µL) and water (84 µL), and the mixture was stirred vigorously at room temperature.
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After completion of the reaction (2 hours, monitored by TLC), ethyl acetate (200 µL) and aqueous ammonia (10 µL) were added. The mixture was filtered, and the filtrate was washed with brine and dried over anhydrous Na 2 SO 4 . After removal of solvent under reduced pressure, the residue was purified by recrystallization with methylene chloride to give the corresponding amine, 4 (a mixture of trans and cis isomers in 1.5:1 ratio). 
Compound 6 (DHP-2) :
x. Hexamethylenediamine (58.1 mg, 0.6 mmol, 1.0 equiv.) was dissolved in CH 2 Cl 2 (2 mL) and cooled to 0 ºC. NBD-SE (25.0 mg, 0.06 mmol, 1.0 equiv.) was then dissolved in the hexamethylenediamine mixture, and the mixture was stirred at room temperature for 2 hours.
Solvents were removed, and the crude mixture was purified by flash column chromatography to obtain compound 6 (15.29 mg, 0.039 mmol, 65%). HDAC buffer was adjusted to pH 2, 4, 6, 7, 8, 10 or 12 with 1 M HCl. Compound 9 was dissolved in HDAC buffer at each pH to obtain 200 µL of a 20 µM solution. The solutions were kept at room temperature and 10 µL aliquots were analyzed at selected time points (t = 0, 5, 10, 15, 30 and 60 minutes). Experiments were carried out in duplicate and the hydrolysis was monitored by HPLC and LCMS. HPLC measurements were made using a gradient elution system composed of water and acetonitrile with 0.01% ammonium formate at a flow rate of 1 S11 mL/min on an Agilent Eclipse XDB-C18 chromatographic column (4.6 mm x l50 mm). LCMS was performed with a gradient elution system composed of water and acetonitrile with 0.1% ammonium formate at a flow rate of 0.1 mL/min using an Agilent Eclipse XDB-C8 chromatographic column (5 µm particle size, 2.1mm x l50 mm). For HP-1, the (M+H) + ion for the corresponding aldehyde (8, DHP-1) was detected, which formed following reaction of the initial imine deacetylation product with water. For HP-2, the (M+H) + .ion for the corresponding amine (6, DHP-2) was identified. The peak area for each detected compound was measured to determine the % deacetylation of each probe. All assay samples were analyzed in triplicate. LCMS measurements were performed with a gradient elution system (5-95%) composed of water and acetonitrile with 0.1% ammonium formate at a flow rate of 0.1 mL/min using an Agilent Eclipse XDB-C8 chromatographic column (5 µm particle size, 2.1mm x l50 mm).
LCMS characterization of HDAC

LCMS analysis of HP-1 cleavage by HDAC3 enzyme over time and determination of the observed rate constant (k obs ) and the half life (T 1/2 )
The rate of cleavage of HP-1 by purified HDAC3 was analyzed by performing a LCMS assay.
Solutions containing 5 µM HP-1 and HDAC3 in HDAC buffer were incubated for 12 hours at 37 ºC. Following incubation, a 20 µL aliquot of supernatant from each sample was analyzed by LCMS at t = 0, 1, 2, 4, 8, and 12h. Deacetylation of HP-1 was confirmed by detection of the (M+H) + ion following positive electrospray ionization. For HP-1, the (M+H) + ion for the corresponding aldehyde (8, DHP-1) was detected, which formed following reaction of the initial imine deacetylation product with water. The peak area for each detected compound was measured to determine the % deacetylation of each probe. The observed rate constant was determined using Graphpad by plotting Ln(DHP-1 peak area) versus time. Assuming that this is a first order reaction, T 1/2 (where, T 1/2 = ln2/k obs ) was estimated. All assay samples were analyzed in triplicate. LCMS measurements were performed with a gradient elution system (5-95%)
composed of water and acetonitrile with 0.1% ammonium formate at a flow rate of 0.1 mL/min
HP-1 deacetylation and protein binding assay
Solutions containing HP-1 (20 µM) in 30 µL HDAC buffer with 5% DMSO were incubated at 37 ºC for four hours in the presence or absence of HDAC3 (3.6 µM). After incubation with HDAC3, NaCNBH 3 (1.4 mM) or vehicle (H 2 O) and BSA (6 mg/mL) or vehicle (HDAC buffer), were added to the solutions prior to an additional incubation at 37 ºC for two hours (all reactions were run in triplicate). Following the second incubation, the final solutions (50 µL) were added to G-25 columns (GE Healthcare, Buckinghamshire, UK) pre-equilibrated with milliQ water. The columns were then centrifuged at 700 × g for 60 seconds before addition of milliQ water (50 µL). The columns were again centrifuged at 700 × g for 60 seconds, and the eluent was combined with the eluent from the first spin to make fraction 1. Following this, 11 samples of water (100 µL each) were added to the columns, the columns were centrifuged as above, and the eluent was 
Imaging HDAC activity in HeLa cells with HP-1 and 2
An acid-washed, poly-lysine-treated sterile glass cover slip was added to each well of 6-well plate, and HeLa cells were plated at a seeding density of ~2. or HP-2. After HP-1 or HP-2 was added, the cells were incubated at 37 °C for 2 hours. Following incubation, the medium was removed and the cells were washed three times with 2 mL HDAC buffer per well. The buffer was removed and 2 mL 4% paraformaldehyde in PBS was added to each well and incubated for 20 minutes at 4 ºC to fix the cells. The fixative was removed and cells were gently washed twice with 2 mL DPBS and twice with 2 mL deionized water. A drop of Gel Mount (anti-fade with DAPI nuclear stain) wasadded to microscope slides, and the cover glasses containing HeLa cells were carefully transferred to the microscope slides. After the slides dried overnight in a dark drawer, they were imaged as described below.
